Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;33(6):634-648.
doi: 10.1111/fcp.12473. Epub 2019 May 23.

Neuroprotective effects of zafirlukast, piracetam and their combination on L-Methionine-induced vascular dementia in rats

Ahmed M Fayez  1 , Ahmed S Elnoby  2   3 , Nada H Bahnasawy  3 , Omar Hassan  1   3
Affiliations

Neuroprotective effects of zafirlukast, piracetam and their combination on L-Methionine-induced vascular dementia in rats

Ahmed M Fayez et al. Fundam Clin Pharmacol. 2019 Dec.

Abstract

Vascular dementia is considered a vascular cognitive impairment disease caused by neuronal degeneration in the brain. Several studies have supported the hypothesis that oxidative stress and endothelial dysfunction are the main pathogenic factors in vascular dementia. This current study aims to determine the possible neuroprotective effects of zafirlukast, piracetam and the combination of piracetam and zafirlukast on L-methionine-induced vascular dementia in rats. Male Wistar albino rats were divided into five groups. Group I was the normal control, and group II received L-methionine (1700 mg/kg, P.O.) for 32 days. The remaining groups received zafirlukast (20 mg/kg, P.O.), piracetam (600 mg/kg, P.O.) or their combination (zafirlukast 20 mg/kg + piracetam 600 mg/kg, P.O.) for 32 days after L-methionine administration. Afterwards, the cognitive and memory performances of the rats were investigated using the novel object recognition (NOR) test; rats were then sacrificed for histopathological and biochemical analyses. L-methionine-induced vascular dementia altered rats' behaviours and the brain contents of different neurotransmitters and acetylcholinesterase activity while increasing levels of oxidative stress and causing notable histopathological alterations in brain tissues. The treatment of vascular dementia with zafirlukast and the combination improved neurochemical, behavioural and histological alterations to a comparable level to those of piracetam. Thus, zafirlukast, piracetam and the combination of both drugs can be considered as potential therapeutic strategies for the treatment of vascular dementia induced by L-methionine. To the best of our knowledge, this study is the first to explore the neuroprotective effects of zafirlukast and piracetam on L-methionine-induced vascular dementia.

Keywords: L-methionine; acetylcholine; amyloid beta; brain; piracetam; vascular dementia; zafirlukast.

PubMed Disclaimer

References

    1. Miyamoto N., Tanaka R., Shimura H. et al. Phosphodiesterase III inhibition promotes differentiation and survival of oligodendrocyte progenitors and enhances regeneration of ischemic white matter lesions in the adult mammalian brain. J. Cereb. Flow Metab. (2010) 30 299-310.
    1. Yanhong O., Chandra M., Venkatesh D. Mild cognitive impairment in adult: a neuropsychological review. Ann. Indian Acad. Neurol. (2013) 16 16310-16318.
    1. Gupta S., Sharma B. Pharmacological modulation of I 1-imidazoline and α 2-adrenoceptors in sub acute brain ischemia induced vascular dementia. Eur. J. Pharmacol. (2014) 723 72380-72390.
    1. Cervellati C., Romani A., Seripa D. et al. Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia. J. Neurol. Sci. (2014) 337 156-161.
    1. Bennett S., Grant M.M., Aldred S. Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology. J. Alzheimers Dis. (2009) 17 245-257. https://doi.org/10.3233/JAD-2009-1041.

LinkOut - more resources